SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-251740
Filing Date
2021-08-20
Accepted
2021-08-19 20:09:56
Documents
14
Period of Report
2021-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d216866d8k.htm   iXBRL 8-K 28957
2 EX-99.1 d216866dex991.htm EX-99.1 9546
6 GRAPHIC g216866g0820032625761.jpg GRAPHIC 4094
  Complete submission text file 0001193125-21-251740.txt   175977

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mirm-20210816.xsd EX-101.SCH 2888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20210816_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20210816_pre.xml EX-101.PRE 11857
7 EXTRACTED XBRL INSTANCE DOCUMENT d216866d8k_htm.xml XML 3478
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 211191462
SIC: 2834 Pharmaceutical Preparations